BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38346161)

  • 1. Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with
    Afkhamipour M; Kaviani F; Dalali S; Piri-Gharaghie T; Doosti A
    Arch Immunol Ther Exp (Warsz); 2024 Jan; 72(1):. PubMed ID: 38346161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CD3
    Xue LJ; Mao XB; Liu XB; Gao H; Chen YN; Dai TT; Shao SW; Chen HM; Chu XY
    Cancer Biol Ther; 2019; 20(6):866-876. PubMed ID: 30786815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-LeoA-DNA Nanoparticles Promoted the Efficacy of Novel LeoA-DNA Vaccination on Mice Against Helicobacter pylori.
    Chaleshtori ZA; Rastegari AA; Nayeri H; Doosti A
    Curr Microbiol; 2024 Apr; 81(5):125. PubMed ID: 38558085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the cagW-based gene vaccine on the immunologic properties of BALB/c mouse: an efficient candidate for Helicobacter pylori DNA vaccine.
    Chehelgerdi M; Doosti A
    J Nanobiotechnology; 2020 Apr; 18(1):63. PubMed ID: 32316990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ICOS
    Urakawa S; Yamasaki M; Makino T; Kurokawa Y; Yamamoto K; Goto K; Haruna M; Hirata M; Morimoto-Okazawa A; Kawashima A; Iwahori K; Mizushima T; Sato E; Mori M; Doki Y; Wada H
    Cancer Immunol Immunother; 2021 Feb; 70(2):443-452. PubMed ID: 32803278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice.
    Nemattalab M; Shenagari M; Taheri M; Mahjoob M; Nazari Chamaki F; Mojtahedi A; Hasan-Alizadeh E; Ashrafkhani B; Mousavi Niri N
    Cytokine; 2020 Feb; 126():154866. PubMed ID: 31629103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine.
    Gong Y; Tao L; Wang F; Liu W; Jing L; Liu D; Hu S; Xie Y; Zhou N
    Mol Med Rep; 2015 Sep; 12(3):4123-4132. PubMed ID: 26095723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolating, immunophenotyping and ex vivo stimulation of CD4+ and CD8+ gastric lymphocytes during murine Helicobacter pylori infection.
    Ruiz VE; Sachdev M; Zhang S; Wen S; Moss SF
    J Immunol Methods; 2012 Oct; 384(1-2):157-63. PubMed ID: 22814402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of CCR6
    Wu YY; Hsieh CT; Tsay GJ; Kao JT; Chiu YM; Shieh DC; Lee YJ
    Helicobacter; 2019 Feb; 24(1):e12550. PubMed ID: 30412323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.
    Xu C; Li ZS; Du YQ; Gong YF; Yang H; Sun B; Jin J
    World J Gastroenterol; 2007 Feb; 13(6):939-44. PubMed ID: 17352028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of circulating integrin α4β7
    Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
    Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4(+) Foxp3(+) regulatory T-cell number increases in the gastric tissue of C57BL/6 mice infected with Helicobacter pylori.
    Liu S; Luo J; Liu Y; Tang S; Chen C; Cai H; Yu M; Zhang Y
    APMIS; 2015 Jul; 123(7):571-9. PubMed ID: 26010562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
    Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
    J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
    Nyström J; Raghavan S; Svennerholm AM
    Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
    Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice.
    Li B; Chen L; Sun H; Yang W; Hu J; He Y; Wei S; Zhao Z; Zhang J; Li H; Zou Q; Wu C
    Sci Rep; 2015 Oct; 5():14793. PubMed ID: 26434384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolin-1 protects B6129 mice against Helicobacter pylori gastritis.
    Hitkova I; Yuan G; Anderl F; Gerhard M; Kirchner T; Reu S; Röcken C; Schäfer C; Schmid RM; Vogelmann R; Ebert MP; Burgermeister E
    PLoS Pathog; 2013; 9(4):e1003251. PubMed ID: 23592983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids.
    Chen J; Lin L; Li N; She F
    Microbiol Immunol; 2012 Feb; 56(2):85-92. PubMed ID: 22150716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.